Arcutis Biotherapeutics, Inc. (ARQT)
$26.58+8.53%Close
SELLRECOVERY · day 96
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.3B
- Beta
- 1.58
- P/E (TTM)
- 108.33
- Short % float
- 19.68%
- Days to cover
- 4.8
- SI change
- +17.5%
- 1W
- +5.64%
- 1M
- +13.69%
- vs SPY 1W
- +4.48%
- vs SPY 1M
- +10.69%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ARQT?
- LOPJLB’s latest quantitative signal on Arcutis Biotherapeutics, Inc. (ARQT) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ARQT in?
- Arcutis Biotherapeutics, Inc. (ARQT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Arcutis Biotherapeutics, Inc. (ARQT) do?
- Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's p…